We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,306 hedge funds and large institutions have $72.6B invested in Thermo Fisher Scientific in 2018 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 423 increasing their positions, 549 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 139 | Existing positions closed: 67

18% more funds holding in top 10

Funds holding in top 10: 89105 (+16)

8% more capital invested

Capital invested by funds: $67.1B → $72.6B (+$5.53B)

5% more funds holding

Funds holding: 1,2461,306 (+60)

0.54% less ownership

Funds ownership: 88.17%87.63% (-0.54%)

16% less call options, than puts

Call options by funds: $204M | Put options by funds: $242M

23% less repeat investments, than reductions

Existing positions increased: 423 | Existing positions reduced: 549

Holders
1,306
Holders Change
+60
Holders Change %
+4.82%
% of All Funds
29.93%
Holding in Top 10
105
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+17.98%
% of All Funds
2.41%
New
139
Increased
423
Reduced
549
Closed
67
Calls
$204M
Puts
$242M
Net Calls
-$37.8M
Net Calls Change
+$96.4M
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
501
BTC Capital Management
Iowa
$5.12M -$714K -3,402 -12%
NWM
502
Nicola Wealth Management
British Columbia, Canada
$5.1M +$5.19M +24,723 New
LG
503
LaFleur & Godfrey
Michigan
$5.1M +$5.19M +24,715 New
CC
504
Cannell & Co
New York
$5.08M -$86.7K -413 -2%
LSERS
505
Louisiana State Employees Retirement System
Louisiana
$5.06M +$42K +200 +0.8%
WAM
506
World Asset Management
Michigan
$5.03M -$1.88M -8,959 -27%
SRC
507
Stone Run Capital
New York
$4.98M -$15.7K -75 -0.3%
BFO
508
Boston Family Office
Massachusetts
$4.95M -$72.8K -347 -1%
APP
509
Avantax Planning Partners
Iowa
$4.95M +$3.36K +16 +0.1%
VIA
510
Vantage Investment Advisors
Pennsylvania
$4.94M +$1.54M +7,324 +44%
RW
511
Rand Wealth
Maryland
$4.93M +$147K +700 +3%
BG
512
Bellevue Group
Switzerland
$4.92M -$411K -1,960 -8%
ECM
513
Endurant Capital Management
California
$4.92M -$4.16M -19,800 -45%
BC
514
Barnett & Company
Tennessee
$4.87M -$126K -600 -2%
HKIM
515
Hayek Kallen Investment Management
Alabama
$4.85M -$216K -1,029 -4%
SLI
516
Sumitomo Life Insurance
Japan
$4.83M -$677K -3,224 -12%
Creative Planning
517
Creative Planning
Kansas
$4.8M +$48.9K +233 +1%
DIA
518
Dana Investment Advisors
Wisconsin
$4.8M +$4.54M +21,623 +1,346%
AI
519
ArchPoint Investors
Florida
$4.79M +$10.7K +51 +0.2%
BPIM
520
Brant Point Investment Management
New York
$4.76M +$24.6K +117 +0.5%
ELI
521
Empire Life Investments
Ontario, Canada
$4.75M -$12.5M -59,758 -72%
OCM
522
Olstein Capital Management
New York
$4.75M
LSCM
523
LaSalle Street Capital Management
Illinois
$4.71M -$653K -3,112 -12%
BBI
524
Baxter Bros Inc
Connecticut
$4.67M +$222K +1,059 +5%
FSA
525
Franklin Street Advisors
North Carolina
$4.66M +$208K +990 +5%

TMO Hedge Fund Activity: Q1 2018 in Review

1,306 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2018, worth a combined $72.6B — up 8.2% from $67.1B a quarter earlier.

Buyers outnumbered sellers: 139 funds opened new TMO positions and 67 closed out — a net gain of 72 holders — while 423 added to existing stakes and 549 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $305M. The largest seller was Massachusetts Financial Services, cutting an estimated $415M.

  • 1,306 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2018, up from 1,246 in Q4 2017.
  • Funds reported $72.6B of Thermo Fisher Scientific stock for Q1 2018, up 8.2% quarter-over-quarter.
  • 139 funds opened new Thermo Fisher Scientific positions in Q1 2018 and 67 closed out, a net change of +72 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2018 was Deutsche Bank, an estimated $305M added.
  • The largest Thermo Fisher Scientific seller in Q1 2018 was Massachusetts Financial Services, an estimated $415M sold.

Based on aggregated 13F filings for Q1 2018.